Quadrant Capital Group LLC Sarepta Therapeutics, Inc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 866 shares of SRPT stock, worth $94,489. This represents 0.01% of its overall portfolio holdings.

Number of Shares

866

Previous 563 53.82%

Holding current value

$94,489

Previous $88,000 22.73%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$124.33 - $156.75 $37,671 - $47,495	303 Added 53.82%	866 $108,000
Q2 2024 Aug 12, 2024	BUY	$113.33 - $163.85 $54,625 - $78,975	482 Added 595.06%	563 $88,000
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $1,124 - $1,698	12 Added 17.39%	81 $10,000
Q4 2023 Feb 08, 2024	BUY	$67.31 - $124.76 $2,086 - $3,867	31 Added 81.58%	69 $6,000
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $102 - $123	1 Added 2.7%	38 $4,000
Q2 2023 Aug 09, 2023	SELL	$106.4 - $157.19 $9,576 - $14,147	-90 Reduced 70.87%	37 $4,000
Q1 2023 May 11, 2023	BUY	$117.53 - $155.99 $11,165 - $14,819	95 Added 296.88%	127 $17,000
Q4 2022 Feb 10, 2023	SELL	$100.86 - $132.13 $2,521 - $3,303	-25 Reduced 43.86%	32 $4,000
Q3 2022 Nov 10, 2022	SELL	$75.71 - $119.24 $6,738 - $10,612	-89 Reduced 60.96%	57 $6,000
Q2 2022 Aug 09, 2022	SELL	$62.69 - $88.44 $10,218 - $14,415	-163 Reduced 52.75%	146 $11,000
Q1 2022 May 06, 2022	SELL	$63.15 - $90.42 $29,364 - $42,045	-465 Reduced 60.08%	309 $24,000
Q4 2021 Feb 01, 2022	SELL	$77.28 - $99.42 $540 - $695	-7 Reduced 0.9%	774 $70,000
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $39,582 - $55,488	600 Added 331.49%	781 $72,000
Q2 2021 Aug 09, 2021	BUY	$69.38 - $86.75 $9,851 - $12,318	142 Added 364.1%	181 $14,000
Q1 2021 May 12, 2021	SELL	$72.25 - $168.95 $2,384 - $5,575	-33 Reduced 45.83%	39 $3,000
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $3,766 - $5,362	30 Added 71.43%	72 $12,000
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $381 - $517	-3 Reduced 6.67%	42 $6,000
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $17,298 - $31,936	-186 Reduced 80.52%	45 $7,000
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $17,958 - $28,697	218 Added 1676.92%	231 $22,000
Q4 2019 Feb 03, 2020	BUY	$76.53 - $135.58 $994 - $1,762	13 New	13 $1,000
Q3 2019 Oct 24, 2019	SELL	$72.81 - $156.91 $28,323 - $61,037	-389 Closed	0 $0
Q2 2019 Jul 24, 2019	SELL	$112.21 - $151.95 $5,834 - $7,901	-52 Reduced 11.79%	389 $58,000
Q1 2019 Apr 29, 2019	BUY	$106.67 - $151.68 $47,041 - $66,890	441 New	441 $51,000
Q4 2018 Jan 17, 2019	SELL	$97.32 - $148.76 $583 - $892	-6 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$115.31 - $161.51 $691 - $969	6 New	6 $0

Others Institutions Holding SRPT

# of Institutions

528

Shares Held

84M

Call Options Held

1.99M

Put Options Held

1.36M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.55B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Sarepta Therapeutics, Inc. Transaction History